RSNA: Agfa to showcase health IT line-up and DR portfolio

TriMed Staff | | Health Imaging | Enterprise Imaging
Agfa HealthCare (Booth 8350) will be highlighting its suite of informatics systems and DR system upgrades at the 97th annual RSNA scientific sessions and annual meeting of RSNA, Nov. 27 to Dec. 2 in Chicago.

Among the products being demonstrated by the Mortsel, Belgium-based company are:
  • Additions to the Agfa DR portfolio, such as Musica2 image processing, the NX graphical user interface and cesium panel technology.
  • Version 2.0 of the Clinical Applications Suite which integrates image processing and information management with the Impax reporting workflow.
  • The Xero viewer, which provides access to healthcare system data on most operating systems and browsers without the need for downloading software.

TriMed Staff

Related Content

RamSoft and Alpha Nodus partner to streamline imaging prior authorization processes
Chinese hackers use malware disguised as imaging viewers to steal patient data
Newly launched report feature provides patients with a visual aid to their imaging
Sectra and Siemens Healthineers partner to improve CT workflows
GE HealthCare taps Enlitic for large-scale imaging data migration plans
Top performing PACS companies based on user feedback

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.